Depressive Disorder, Major: all 2,806 studies
Page 15 of 29. Open to participants first (566), then studies with results posted, then the rest; newest registration first within each.
- Feasibility and ML Training Investigation of the Senseye DT for Diagnosis of Adults with PTSDCompletedNCT05717439
- Deep Brain Stimulation for Treatment Resistant DepressionStatus unknownNCT05716555Not applicable
- Phase 2b Study of ALTO-100 in MDDCompletedNCT05712187Phase 2
- N2O for Acute Suicidality and Depression in the EDWithdrawnNCT05710887Phase 2
- Sleep Signal Analysis for Current Major Depressive Episode (SAMDE)CompletedNCT05708222
- The Effect of Intradermal Acupuncture on Gallbladder Meridian Points on Cerebral Hemodynamics in Relevant Brain Regions for Major Depressive Disorder Based on fNIRS TechnologyStatus unknownNCT05707299Not applicable
- Study of Virtual Reality-based Medical Device for Patients with Depressive DisorderCompletedNCT05701345Not applicable
- Neuro MRI Biomarkers for Treatment Navigation in DepressionCompletedNCT05701267
- Low Intensity Ultrasound Neuromodulation of Repetitive Negative Thinking In DepressionCompletedNCT05697172Not applicable
- Feasibility of Resistance Exercise to Treat Major Depression Via Cerebrovascular MechanismsCompletedNCT05695365Not applicable
- Transcranial Magnetic Stimulation Theta Burst (TMS), Depression and Smoking.Status unknownNCT05694754Not applicable
- Musical Attention Control and Executive Function Training for Adults With MDDCompletedNCT05694156Not applicable
- Evolution of the Sensory Profile in DepressionCompletedNCT05686668
- A Treatment for Depression Via a Gamified Mobile Phone Application Based on a New Cognitive ModelCompletedNCT05685758Not applicable
- Multi-domain Psychoeducation Self-management Program for Adults With MDD in SingaporeStatus unknownNCT05682183Not applicable
- Psilocybin for Major Depressive DisorderWithdrawnNCT05675800Phase 2
- An Open-label, Adaptive Design, Positron Emission Tomography Study in Healthy Male Participants to Characterize Receptor Occupancy by MIJ821 in the BrainCompletedNCT05666687Phase 1
- Xanamem® in Adults with Major Depressive Disorder and Impaired Cognition (XanaCIDD)CompletedNCT05657691Phase 2
- Zuranolone Pharmacokinetics (PK) and Safety Study Adolescent Participants With Major Depressive Disorder (MDD)CompletedNCT05655507Phase 1
- Transcranial Magnetic Stimulation for Youth With Treatment-Resistant Major Depressive DisorderWithdrawnNCT05652465Phase 2
- IM and IV SPL026 Drug Product in Healthy ParticipantsCompletedNCT05644093Phase 1
- "Mamá, te Entiendo" App-based Intervention for Reducing Depressive Symptoms in Postpartum WomenStatus unknownNCT05643898Not applicable
- Impact of Covid-19 Pandemic on Patients Receiving Continuation or Maintenance Electroconvulsive TherapyCompletedNCT05633368
- Prediction of Antidepressant Effects of Electroconvulsive TherapyCompletedNCT05630469
- Predictors of Intravenous Ketamine Response in TRDActive, not recruitingNCT05625555Phase 3
- Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for DepressionCompletedNCT05615948Phase 4
- Efficacy and Safety of Intradermal Acupuncture for Major Depressive DisorderStatus unknownNCT05605002Not applicable
- Clinical Validation Study for EDIT-B Test: an Aid for Differential Diagnosis of Bipolar Disorder, Based on RNA Editing Blood BiomarkersCompletedNCT05603819
- PET Synaptogenesis After Psilocybin In DEpression RecoveryWithdrawnNCT05601648Phase 2
- Multiple Ascending Dose and Electroencephalography Trial of GATE-202 in Healthy VolunteersCompletedNCT05597241Phase 1
- Effect of SSRIs on Response to Psilocybin TherapyWithdrawnNCT05594667Phase 2
- A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive DisorderCompletedNCT05593029Phase 2
- D-Cycloserine Augmentation of Intermittent Theta Burst Stimulation (iTBS) in Depression (COGENT)Active, not recruitingNCT05591677Phase 2
- A Trial of Enhanced Versus Standard Measurement-Based Care Implementation for DepressionStatus unknownNCT05577494
- The Effect of Soluble Epoxide Hydrolase (SEH) on DepressionCompletedNCT05575713
- Is Brain Insulin Resistance a Feature of the Biology of Depression in AdolescentsCompletedNCT05571878Not applicable
- Biomarkers of ANTidepressant RESponse and Development Risk of Bipolar DisorderStatus unknownNCT05568823Not applicable
- VA Aripiprazole vs Esketamine for Treatment Resistant DepressionWithdrawnNCT05554627Phase 4
- SPL026 With or Without SSRIs in Participants With MDDCompletedNCT05553691Phase 1
- Transcranial Pulse Stimulation for DepressionCompletedNCT05551585Not applicable
- An Energetic View on Creativity, Psychopathology and Intelligence: The Brain2Business StudyCompletedNCT05544877Not applicable
- Individualized dlPFC-NAcc Modulation for Anhedonia in adMDDCompletedNCT05544071Not applicable
- Transcranial Magnetic Stimulation in Patients With a Depressive Episode - RCT TrialStatus unknownNCT05543421Not applicable
- Retrospective TMS Therapy for Adults With MDDCompletedNCT05541302
- Exercise Recovery From Persistent Depression: A Thematic AnalysisCompletedNCT05539495
- SMART Trial to Predict Anhedonia Response to Antidepressant TreatmentCompletedNCT05537584Phase 4
- Precision Medicine for the Prediction of Treatment (PROMPT) Response (PROMPT)Status unknownNCT05537558
- Trial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive DisorderCompletedNCT05536414Phase 2
- RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)CompletedNCT05531591Phase 4
- An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety PersonnelActive, not recruitingNCT05530642Not applicable
- Multi-factor Model Constraction for Early Warning and Diagnosis of MDDStatus unknownNCT05529576Phase 4
- SMILE Trial - Imaging Sub-StudyCompletedNCT05528718
- Enhanced Measurement-Based Care Effectiveness for Depression (EMBED) StudyStatus unknownNCT05527951Not applicable
- Extended Reality Behavioral Activation: An Intervention for Major Depressive DisorderCompletedNCT05525390Not applicable
- Intradermal Acupuncture Based on Changes in Biological Specificity of Acupoints for Major Depressive DisorderCompletedNCT05524519Not applicable
- Transdiagnostic Markers of Cognitive Symptoms in Disorders Affective.CompletedNCT05523076
- TF-CBT for Long-term PTSD, Major Depressive Disorder and Anxiety Disorders in Victims of TerrorismCompletedNCT05516368Not applicable
- The Antidepressant Effect of Intermittent Theta Burst Stimulation (iTBS)CompletedNCT05516095Not applicable
- An EEG Study of Intravenous Ketamine for Major Depression DisorderStatus unknownNCT05506462Phase 4
- Open-label Brexpiprazole fMRI Trial in Adults With Major Depressive Disorder and AnxietyWithdrawnNCT05504486Phase 4
- Efficacy and Safety of Light Therapy in the Treatment of Non-seasonal Depressive Disorder in Chinese PopulationStatus unknownNCT05499117Not applicable
- Neuroimaging Sleep and Mood in DepressionCompletedNCT05497414Not applicable
- VR-Moodboost; an Innovative Virtual Reality Treatment for Adolescents With DepressionCompletedNCT05486676Not applicable
- Personalized Repetitive Transcranial Magnetic Stimulation Treatment for Major Depressive EpisodeCompletedNCT05465928Not applicable
- Pulse Width 0.15ms vs 0.30ms in Electroconvulsive TherapyStatus unknownNCT05465915Early Phase 1
- Digital Therapeutic for Adolescent Depressive Symptoms in Cardiology and GastroenterologyTerminatedNCT05461599Not applicable
- Using Functional MRI Neurofeedback to Modulate Self-blame in Major Depressive DisorderCompletedNCT05455827Not applicable
- Smartphone App Based CBT Versus Online Group CBT: Randomized, Non-inferiority Clinical TrialStatus unknownNCT05450614Not applicable
- Repeated Intranasal Esketamine Plus Almond Therapy in Participants With Treatment Resistant Depressive Disorder - 3 Month Extension StudyWithdrawnNCT05438758Phase 2
- Near-infrared Transcranial Laser Therapy in Subjects With Major Depressive Disorder: A Study of Dosing With LaserCompletedNCT05435820Not applicable
- ELE-101 Safety & Tolerability Study in Healthy Participants and Patients With DepressionActive, not recruitingNCT05434156Phase 1/2
- Measurement-Based Care Vs. Standard Care for Major Depressive DisorderCompletedNCT05431374Not applicable
- Anti-suicidal Effects of Buprenorphine In Depressed IndividualsWithdrawnNCT05427981Phase 3
- Emotion Regulation Training to Reduce Cardiovascular Disease Risk Among Depressed Young Adults in Southern MississippiCompletedNCT05425290Not applicable
- The Efficacy of Acupressure Therapy on Patient With DepressionStatus unknownNCT05423405Not applicable
- Pilot Decentralized TrialCompletedNCT05419869Phase 2
- Single Dose Oral Bioequivalence Study of Vortioxetine Hemihydrobromide Orally Disintegrating TabletsCompletedNCT05417087Phase 1
- Food Effect Bioavailability Study of Vortioxetine Hemihydrobromide Orally Disintegrating TabletsCompletedNCT05416957Phase 1
- Single Dose Study to Evaluate Dose-proportionality of Vortioxetine Hemihydrobromide Orally Disintegrating TabletsCompletedNCT05416762Phase 1
- Treating Immuno-metabolic Depression With Anti-inflammatory DrugsCompletedNCT05415397Phase 3
- The RAFT ECT StudyCompletedNCT05402657Not applicable
- Efficacy of the Mobile Application for Prediction and Prevention of Mood Episode Recurrence Based on Machine LearningCompletedNCT05400785Not applicable
- Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality DisorderCompletedNCT05399498Phase 2
- Treatment for Major Depressive Disorder With Intermittent Theta-burst StimulationStatus unknownNCT05390593Not applicable
- TBS Treatment for Treatment-Resistant DepressionCompletedNCT05388539Not applicable
- A Study of a Psilocybin Analog (CYB003) in Healthy Participants With and Without Major Depressive DisorderCompletedNCT05385783Phase 1/2
- The Effects of Psilocybin on Self-Focus and Self-Related Processing in Treatment Resistant MDDWithdrawnNCT05381974Phase 2
- Peripheral Neuroimmune Mechanisms of HyperthermiaStatus unknownNCT05366270Not applicable
- Antidepressant Effects of Nitrous OxideWithdrawnNCT05357040Phase 2
- Type 1 Diabetes and Depression: Role of Brain GlutamateCompletedNCT05355285Not applicable
- Virtual Mindfulness Training for Adults With History of DepressionCompletedNCT05347719Not applicable
- Effects of a Single Dose of Amisulpride on Functional Brain ChangesCompletedNCT05347199Phase 1
- Pentoxifylline for Treatment of Resistant Major DepressionCompletedNCT05324735Phase 1/2
- Repeated Intranasal Esketamine Plus Almond Therapy in Patients With Treatment Resistant DepressionTerminatedNCT05323019Phase 2
- Effects of Ghrelin Administration on Dopamine and EffortCompletedNCT05318924Phase 1/2
- The Efficacy of Probiotic Compared With Placebo Commitment Therapy for Treatment of Major Depressive DisorderWithdrawnNCT05315401Phase 2
- Prospective Assessment of Cost-effectiveness and Side-effects of Depressive Patients Treated With ECT or TCAActive, not recruitingNCT05306184
- Effects of Cognitive-Oriented Intervention on Major Depressive DisorderCompletedNCT05296174Not applicable
- First choIce Antidepressants: General Practitioner's Treatment Approach in the Czech RepublicTerminatedNCT05291897
- Microbiotherapy in Characterized Depressive DisorderStatus unknownNCT05280015Phase 2